AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2025
Jun 23, 2025
31580_dirs_2025-06-23_55492f45-dc06-45a9-95e1-7ca6106dfa14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK: 0001439222
Period of Report: 2025-06-18
Reporting Person: CAPELLO JEFFREY D (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-20 | Common stock | M | 2120 | — | Acquired | 6073 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-18 | Restricted stock units | $ | A | 2861 | Acquired | Common stock (2861) | Direct | |
| 2025-06-18 | Stock options (right to buy) | $35.50 | A | 15768 | Acquired | 2035-06-18 | Common stock (15768) | Direct |
| 2025-06-20 | Restricted stock units | $ | M | 2120 | Disposed | Common stock (2120) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
F3: These options were granted on June 18, 2025. The shares underlying this option vest as to 100% of the underlying shares on June 18, 2026.
F4: The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested.